Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gale

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
Plos Pathogens|April 12, 2019
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infectionTiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, et al.
The Journal of Experimental Medicine|August 8, 2022
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2022
Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral cultureMichalina A Montaño, Meagan J Bemer, Kate B Heller, et al.
The Journal of Experimental Medicine|August 29, 2022
Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine|July 30, 2025
Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathologyBenjamin H Gern, Josepha M Klas, Kimberly A Foster, et al.
Journal of Virology|March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Ebiomedicine|August 6, 2022
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccineDavid W Hawman, Kimberly Meade-White, Chad Clancy, et al.
JCI Insight|November 12, 2021
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populationsLouisa Helms, Silvia Marchiano, Ian B Stanaway, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2022
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 VariantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Mucosal Immunology|December 5, 2019
Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaquesJennifer A Manuzak, Alexander S Zevin, Ryan Cheu, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
Plos Pathogens|April 12, 2019
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infectionTiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, et al.
The Journal of Experimental Medicine|August 8, 2022
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2022
Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral cultureMichalina A Montaño, Meagan J Bemer, Kate B Heller, et al.
The Journal of Experimental Medicine|August 29, 2022
Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine|July 30, 2025
Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathologyBenjamin H Gern, Josepha M Klas, Kimberly A Foster, et al.
Journal of Virology|March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Ebiomedicine|August 6, 2022
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccineDavid W Hawman, Kimberly Meade-White, Chad Clancy, et al.
JCI Insight|November 12, 2021
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populationsLouisa Helms, Silvia Marchiano, Ian B Stanaway, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2022
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 VariantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Mucosal Immunology|December 5, 2019
Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaquesJennifer A Manuzak, Alexander S Zevin, Ryan Cheu, et al.
Pageof 36